Decompositions of dithranol and butantrone (10-butyryldithranol) were studied in buffer solutions. Half lives at pH 9.4, 7.4 and 6.5 were 0.6, 1.2 and 3.0 h for dithranol, and 1.3, 15 and 30 h for butantrone, respectively. 1,8-Dihydroxyanthraquinone accounted for 50 % of the decomposition products from dithranol and for 20 % of those from butantrone at pH 9.4. Dithranol was not found as the decomposition product of butantrone. Based on kinetic considerations it is suggested that butantrone anion rather than dithranol anion is the intermediate of the main reaction in the oxidation of butantrone to 1,8-dihydroxyanthraquinone. Dithranol (anthralin, l&dihydroxyanthrone) has been the mainstay of topical treatment of psoriasis for over 60 years. Dithranol does, however, irritate the skin when oxidized and, apart from being therapeutically inactive, the final oxidation products also cause staining of the skin and clothing. The major decomposition and polymerization products are shown in Fig. 1. The detailed mechanism of the antipsoriatic activity of dithranol and its derivatives is not known. The minimum structural requirement for activity is proposed by Krebs and SchaZtegger3)to be a free methylene group at C-10. Because 10-acyl derivatives do not fulfil this requirement, they are supposed to be pro-drugs of dithranol cleaved in the skin to their parent compound4! Instead of dithranol Schaitegger and co-workers found in their study of in vitro hydrolysis of 10-acyl dithranols one of the oxidation products of dithranol, 1,8-dihydroxy anthraquinone. It was concluded that dithrano1 formed from 10-acyl derivatives is oxidized too quickly to be detected.From the point of view of structure-activity relationship of dithranol derivatives and the mechanism of their antipsoriatic activity it is of great interest to know whether 10-acyl dithranol derivatives are hydrolyzed to dithranol and at what rate. Therefore, a more quantitative study was undertaken on the in vitro decomposition of dithranol and 10-butyryl dithranol and on the formation of 1,8-dihydroxyanthraquinone.Recently, several 10-acylated derivatives of dithranol have been developed and tested in Finland as potential autipsoriatics ', 2! 10-Butyryl dithranol (butantrone, INN) is the best in terms Of to dithranol in antipsoriatic efficacy. In these 1 0-acylated derivatives of dithranol the acYl group diminishes considerably the formation of coloured oxidation products, they are therefore less staining.used without further purification.
Experimental part
CompoundsButantrone was synthesized at Orion Pharmaceutica. Dithranol was BP quality, 1,8-dihydroxyanthraquinone was purchased from Fluka AG (Bruchs, Switzerland), and the glucose used for buffer solution was Ph. Eur. quality. All the other chemicals and reagents were reagent grade,
104Halmekoski and Coworkers
BuffersThe buffers were phosphate (pH 6.5 and 7.4) and N-2-hydroxyethylpiperazine-N-ethanesulfonic acid (Hepes, pH 9.4) buffers. The phosphate buffers were prepared by mixing 0.2 M disodium phosphate and 0.1 M ci...